Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

ClinicalTrials.gov ID: NCT00262600

Public ClinicalTrials.gov record NCT00262600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate With Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation: Prospective, Multi-centre, Parallel-group, Non-inferiority Trial (RE-LY Study)

Study identification

NCT ID
NCT00262600
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
18,113 participants

Conditions and interventions

Interventions

  • warfarin Drug
  • Dabigatran dose 1 Drug
  • Dabigatran dose 2 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2005
Primary completion
Mar 31, 2009
Completion
Not listed
Last update posted
Apr 16, 2019

Started 2005

United States locations

U.S. sites
374
U.S. states
46
U.S. cities
289
Facility City State ZIP Site status
1160.26.0009 Boehringer Ingelheim Investigational Site Birmingham Alabama
1160.26.0046 Boehringer Ingelheim Investigational Site Birmingham Alabama
1160.26.0057 Boehringer Ingelheim Investigational Site Birmingham Alabama
1160.26.0211 Boehringer Ingelheim Investigational Site Birmingham Alabama
1160.26.0206 Boehringer Ingelheim Investigational Site Huntsville Alabama
1160.26.0115 Boehringer Ingelheim Investigational Site Mobile Alabama
1160.26.0104 Boehringer Ingelheim Investigational Site Lake Havasu City Arizona
1160.26.0304 Boehringer Ingelheim Investigational Site Peoria Arizona
1160.26.0185 Boehringer Ingelheim Investigational Site Tucson Arizona
1160.26.0305 Boehringer Ingelheim Investigational Site Tucson Arizona
1160.26.0038 Boehringer Ingelheim Investigational Site Hot Springs Arkansas
1160.26.0302 Boehringer Ingelheim Investigational Site Jonesboro Arkansas
1160.26.0121 Boehringer Ingelheim Investigational Site Little Rock Arkansas
1160.26.0191 Boehringer Ingelheim Investigational Site Little Rock Arkansas
1160.26.0204 Boehringer Ingelheim Investigational Site Little Rock Arkansas
1160.26.0213 Boehringer Ingelheim Investigational Site Little Rock Arkansas
1160.26.0455 Boehringer Ingelheim Investigational Site Little Rock Arkansas
1160.26.0388 Boehringer Ingelheim Investigational Site Anaheim California
1160.26.0441 Boehringer Ingelheim Investigational Site Carmichael California
1160.26.0145 Boehringer Ingelheim Investigational Site French Camp California
1160.26.0333 Boehringer Ingelheim Investigational Site Fullerton California
1160.26.0384 Boehringer Ingelheim Investigational Site La Jolla California
1160.26.0091 Boehringer Ingelheim Investigational Site La Mesa California
1160.26.0246 Boehringer Ingelheim Investigational Site Lancaster California
1160.26.0345 Boehringer Ingelheim Investigational Site Larkspur California
1160.26.0217 Boehringer Ingelheim Investigational Site Loma Linda California
1160.26.0059 Boehringer Ingelheim Investigational Site Los Angeles California
1160.26.0088 Boehringer Ingelheim Investigational Site Los Angeles California
1160.26.0337 Boehringer Ingelheim Investigational Site Los Angeles California
1160.26.0326 Boehringer Ingelheim Investigational Site Mather California
1160.26.0070 Boehringer Ingelheim Investigational Site Merced California
1160.26.0349 Boehringer Ingelheim Investigational Site Oakland California
1160.26.0016 Boehringer Ingelheim Investigational Site Oceanside California
1160.26.0087 Boehringer Ingelheim Investigational Site Palm Springs California
1160.26.0459 Boehringer Ingelheim Investigational Site Pasadena California
1160.26.0216 Boehringer Ingelheim Investigational Site Redondo Beach California
1160.26.0135 Boehringer Ingelheim Investigational Site Riverside California
1160.26.0162 Boehringer Ingelheim Investigational Site Sacramento California
1160.26.0300 Boehringer Ingelheim Investigational Site Sacramento California
1160.26.0371 Boehringer Ingelheim Investigational Site Sacramento California
1160.26.0116 Boehringer Ingelheim Investigational Site San Diego California
1160.26.0148 Boehringer Ingelheim Investigational Site San Diego California
1160.26.0270 Boehringer Ingelheim Investigational Site San Diego California
1160.26.0284 Boehringer Ingelheim Investigational Site San Diego California
1160.26.0351 Boehringer Ingelheim Investigational Site Santa Ana California
1160.26.0043 Boehringer Ingelheim Investigational Site Santa Rosa California
1160.26.0462 Boehringer Ingelheim Investigational Site Sylmar California
1160.26.0276 Boehringer Ingelheim Investigational Site Torrance California
1160.26.0379 Boehringer Ingelheim Investigational Site Walnut Creek California
1160.26.0419 Boehringer Ingelheim Investigational Site Aurora Colorado
1160.26.0321 Boehringer Ingelheim Investigational Site Colorado Springs Colorado
1160.26.0449 Boehringer Ingelheim Investigational Site Colorado Springs Colorado
1160.26.0360 Boehringer Ingelheim Investigational Site Denver Colorado
1160.26.0413 Boehringer Ingelheim Investigational Site Denver Colorado
1160.26.0362 Boehringer Ingelheim Investigational Site Fort Collins Colorado
1160.26.0399 Boehringer Ingelheim Investigational Site Greeley Colorado
1160.26.0058 Boehringer Ingelheim Investigational Site Bridgeport Connecticut
1160.26.0241 Boehringer Ingelheim Investigational Site Bridgeport Connecticut
1160.26.0278 Boehringer Ingelheim Investigational Site Bridgeport Connecticut
1160.26.0085 Boehringer Ingelheim Investigational Site Fairfield Connecticut
1160.26.0482 Boehringer Ingelheim Investigational Site Guilford Connecticut
1160.26.0366 Boehringer Ingelheim Investigational Site Newark Delaware
1160.26.0343 Boehringer Ingelheim Investigational Site Washington D.C. District of Columbia
1160.26.0022 Boehringer Ingelheim Investigational Site Atlantis Florida
1160.26.0382 Boehringer Ingelheim Investigational Site Boynton Beach Florida
1160.26.0056 Boehringer Ingelheim Investigational Site Brandon Florida
1160.26.0105 Boehringer Ingelheim Investigational Site Clearwater Florida
1160.26.0296 Boehringer Ingelheim Investigational Site Clearwater Florida
1160.26.0429 Boehringer Ingelheim Investigational Site Clearwater Florida
1160.26.0376 Boehringer Ingelheim Investigational Site Daytona Beach Florida
1160.26.0411 Boehringer Ingelheim Investigational Site Deerfield Beach Florida
1160.26.0074 Boehringer Ingelheim Investigational Site Fort Myers Florida
1160.26.0239 Boehringer Ingelheim Investigational Site Gainesville Florida
1160.26.0260 Boehringer Ingelheim Investigational Site Hollywood Florida
1160.26.0265 Boehringer Ingelheim Investigational Site Hollywood Florida
1160.26.0100 Boehringer Ingelheim Investigational Site Inverness Florida
1160.26.0033 Boehringer Ingelheim Investigational Site Jacksonville Florida
1160.26.0089 Boehringer Ingelheim Investigational Site Jacksonville Florida
1160.26.0232 Boehringer Ingelheim Investigational Site Jacksonville Florida
1160.26.0240 Boehringer Ingelheim Investigational Site Jacksonville Florida
1160.26.0427 Boehringer Ingelheim Investigational Site Jacksonville Florida
1160.26.0464 Boehringer Ingelheim Investigational Site Jacksonville Florida
1160.26.0209 Boehringer Ingelheim Investigational Site Jacksonville Beach Florida
1160.26.0012 Boehringer Ingelheim Investigational Site Lakeland Florida
1160.26.0259 Boehringer Ingelheim Investigational Site Melbourne Florida
1160.26.0358 Boehringer Ingelheim Investigational Site Melbourne Florida
1160.26.0034 Boehringer Ingelheim Investigational Site Miami Florida
1160.26.0199 Boehringer Ingelheim Investigational Site Miami Florida
1160.26.0227 Boehringer Ingelheim Investigational Site Orlando Florida
1160.26.0095 Boehringer Ingelheim Investigational Site Ormond Beach Florida
1160.26.0037 Boehringer Ingelheim Investigational Site Pensacola Florida
1160.26.0076 Boehringer Ingelheim Investigational Site Pensacola Florida
1160.26.0081 Boehringer Ingelheim Investigational Site Pensacola Florida
1160.26.0111 Boehringer Ingelheim Investigational Site Pensacola Florida
1160.26.0137 Boehringer Ingelheim Investigational Site Port Charlotte Florida
1160.26.0389 Boehringer Ingelheim Investigational Site Port Charlotte Florida
1160.26.0417 Boehringer Ingelheim Investigational Site Port Charlotte Florida
1160.26.0332 Boehringer Ingelheim Investigational Site Rockledge Florida
1160.26.0226 Boehringer Ingelheim Investigational Site Safety Harbor Florida
1160.26.0031 Boehringer Ingelheim Investigational Site Sarasota Florida
1160.26.0385 Boehringer Ingelheim Investigational Site Sarasota Florida
1160.26.0015 Boehringer Ingelheim Investigational Site St. Petersburg Florida
1160.26.0339 Boehringer Ingelheim Investigational Site St. Petersburg Florida
1160.26.0010 Boehringer Ingelheim Investigational Site Stuart Florida
1160.26.0327 Boehringer Ingelheim Investigational Site Tamarac Florida
1160.26.0271 Boehringer Ingelheim Investigational Site Tampa Florida
1160.26.0328 Boehringer Ingelheim Investigational Site Tampa Florida
1160.26.0381 Boehringer Ingelheim Investigational Site Tampa Florida
1160.26.0019 Boehringer Ingelheim Investigational Site Vero Beach Florida
1160.26.0159 Boehringer Ingelheim Investigational Site Atlanta Georgia
1160.26.0283 Boehringer Ingelheim Investigational Site Atlanta Georgia
1160.26.0338 Boehringer Ingelheim Investigational Site Atlanta Georgia
1160.26.0021 Boehringer Ingelheim Investigational Site Augusta Georgia
1160.26.0319 Boehringer Ingelheim Investigational Site Augusta Georgia
1160.26.0092 Boehringer Ingelheim Investigational Site Blue Ridge Georgia
1160.26.0161 Boehringer Ingelheim Investigational Site Conyers Georgia
1160.26.0026 Boehringer Ingelheim Investigational Site Coeur d'Alene Idaho
1160.26.0218 Boehringer Ingelheim Investigational Site Berwyn Illinois
1160.26.0184 Boehringer Ingelheim Investigational Site Chicago Illinois
1160.26.0233 Boehringer Ingelheim Investigational Site Chicago Illinois
1160.26.0324 Boehringer Ingelheim Investigational Site Chicago Illinois
1160.26.0457 Boehringer Ingelheim Investigational Site Chicago Illinois
1160.26.0237 Boehringer Ingelheim Investigational Site Evanston Illinois
1160.26.0236 Boehringer Ingelheim Investigational Site Glenview Illinois
1160.26.0396 Boehringer Ingelheim Investigational Site Hines Illinois
1160.26.0438 Boehringer Ingelheim Investigational Site Maywood Illinois
1160.26.0331 Boehringer Ingelheim Investigational Site Melrose Park Illinois
1160.26.0364 Boehringer Ingelheim Investigational Site Normal Illinois
1160.26.0109 Boehringer Ingelheim Investigational Site North Chicago Illinois
1160.26.0152 Boehringer Ingelheim Investigational Site Oak Lawn Illinois
1160.26.0198 Boehringer Ingelheim Investigational Site Rockford Illinois
1160.26.0433 Boehringer Ingelheim Investigational Site Winfield Illinois
1160.26.0041 Boehringer Ingelheim Investigational Site Evansville Indiana
1160.26.0377 Boehringer Ingelheim Investigational Site Fort Wayne Indiana
1160.26.0288 Boehringer Ingelheim Investigational Site Indianapolis Indiana
1160.26.0352 Boehringer Ingelheim Investigational Site Indianapolis Indiana
1160.26.0436 Boehringer Ingelheim Investigational Site Indianapolis Indiana
1160.26.0028 Boehringer Ingelheim Investigational Site Jeffersonville Indiana
1160.26.0235 Boehringer Ingelheim Investigational Site South Bend Indiana
1160.26.0268 Boehringer Ingelheim Investigational Site Dubuque Iowa
1160.26.0001 Boehringer Ingelheim Investigational Site West Des Moines Iowa
1160.26.0189 Boehringer Ingelheim Investigational Site West Des Moines Iowa
1160.26.0357 Boehringer Ingelheim Investigational Site West Des Moines Iowa
1160.26.0354 Boehringer Ingelheim Investigational Site Wichita Kansas
1160.26.0077 Boehringer Ingelheim Investigational Site Bowling Green Kentucky
1160.26.0138 Boehringer Ingelheim Investigational Site Crestview Hills Kentucky
1160.26.0422 Boehringer Ingelheim Investigational Site Lexington Kentucky
1160.26.0178 Boehringer Ingelheim Investigational Site Louisville Kentucky
1160.26.0397 Boehringer Ingelheim Investigational Site Louisville Kentucky
1160.26.0310 Boehringer Ingelheim Investigational Site Owensboro Kentucky
1160.26.0011 Boehringer Ingelheim Investigational Site Baton Rouge Louisiana
1160.26.0144 Boehringer Ingelheim Investigational Site Baton Rouge Louisiana
1160.26.0404 Boehringer Ingelheim Investigational Site Baton Rouge Louisiana
1160.26.0093 Boehringer Ingelheim Investigational Site Covington Louisiana
1160.26.0340 Boehringer Ingelheim Investigational Site Lacombe Louisiana
1160.26.0018 Boehringer Ingelheim Investigational Site Lafayette Louisiana
1160.26.0391 Boehringer Ingelheim Investigational Site Lafayette Louisiana
1160.26.0252 Boehringer Ingelheim Investigational Site Morgan City Louisiana
1160.26.0132 Boehringer Ingelheim Investigational Site New Iberia Louisiana
1160.26.0299 Tulane University School Of Medicine New Orleans Louisiana
1160.26.0048 Boehringer Ingelheim Investigational Site Shreveport Louisiana
1160.26.0096 Boehringer Ingelheim Investigational Site Auburn Maine
1160.26.0068 Boehringer Ingelheim Investigational Site Scarborough Maine
1160.26.0114 Boehringer Ingelheim Investigational Site Annapolis Maryland
1160.26.0164 Boehringer Ingelheim Investigational Site Annapolis Maryland
1160.26.0023 Boehringer Ingelheim Investigational Site Baltimore Maryland
1160.26.0047 Boehringer Ingelheim Investigational Site Baltimore Maryland
1160.26.0079 Boehringer Ingelheim Investigational Site Baltimore Maryland
1160.26.0186 Boehringer Ingelheim Investigational Site Baltimore Maryland
1160.26.0194 Boehringer Ingelheim Investigational Site Baltimore Maryland
1160.26.0255 Boehringer Ingelheim Investigational Site Bel Air Maryland
1160.26.0398 Boehringer Ingelheim Investigational Site Columbia Maryland
1160.26.0177 Boehringer Ingelheim Investigational Site Rockville Maryland
1160.26.0073 Boehringer Ingelheim Investigational Site Salisbury Maryland
1160.26.0207 Boehringer Ingelheim Investigational Site Salisbury Maryland
1160.26.0196 Boehringer Ingelheim Investigational Site Takoma Park Maryland
1160.26.0187 Boehringer Ingelheim Investigational Site Towson Maryland
1160.26.0052 Boehringer Ingelheim Investigational Site Westminster Maryland
1160.26.0042 Boehringer Ingelheim Investigational Site Ayer Massachusetts
1160.26.0401 Boehringer Ingelheim Investigational Site Boston Massachusetts
1160.26.0160 Boehringer Ingelheim Investigational Site East Bridgewater Massachusetts
1160.26.0443 Boehringer Ingelheim Investigational Site Haverhill Massachusetts
1160.26.0452 Boehringer Ingelheim Investigational Site Haverhill Massachusetts
1160.26.0029 Boehringer Ingelheim Investigational Site Natick Massachusetts
1160.26.0446 Boehringer Ingelheim Investigational Site Newtown Massachusetts
1160.26.0003 Boehringer Ingelheim Investigational Site North Dartmouth Massachusetts
1160.26.0470 Boehringer Ingelheim Investigational Site Northborough Massachusetts
1160.26.0308 Boehringer Ingelheim Investigational Site Worcester Massachusetts
1160.26.0141 Boehringer Ingelheim Investigational Site Bloomfield Hills Michigan
1160.26.0225 Boehringer Ingelheim Investigational Site Detroit Michigan
1160.26.0154 Boehringer Ingelheim Investigational Site Grand Blanc Michigan
1160.26.0030 Boehringer Ingelheim Investigational Site Grand Rapids Michigan
1160.26.0171 Boehringer Ingelheim Investigational Site Kalamazoo Michigan
1160.26.0205 Boehringer Ingelheim Investigational Site Lapeer Michigan
1160.26.0279 Boehringer Ingelheim Investigational Site Muskegon Michigan
1160.26.0445 Boehringer Ingelheim Investigational Site Petoskey Michigan
1160.26.0274 Boehringer Ingelheim Investigational Site Rochester Hills Michigan
1160.26.0165 Boehringer Ingelheim Investigational Site Saginaw Michigan
1160.26.0020 Boehringer Ingelheim Investigational Site Troy Michigan
1160.26.0188 Boehringer Ingelheim Investigational Site Ypsilanti Michigan
1160.26.0131 Boehringer Ingelheim Investigational Site Minneapolis Minnesota
1160.26.0421 Boehringer Ingelheim Investigational Site Minneapolis Minnesota
1160.26.0202 Boehringer Ingelheim Investigational Site Robbinsdale Minnesota
1160.26.0101 Boehringer Ingelheim Investigational Site Saint Paul Minnesota
1160.26.0086 Boehringer Ingelheim Investigational Site Gulfport Mississippi
1160.26.0119 Boehringer Ingelheim Investigational Site Tupelo Mississippi
1160.26.0055 Boehringer Ingelheim Investigational Site Columbia Missouri
1160.26.0172 Boehringer Ingelheim Investigational Site Columbia Missouri
1160.26.0257 Boehringer Ingelheim Investigational Site Kansas City Missouri
1160.26.0266 Boehringer Ingelheim Investigational Site Kansas City Missouri
1160.26.0336 Boehringer Ingelheim Investigational Site Saint Charles Missouri
1160.26.0249 Boehringer Ingelheim Investigational Site St Louis Missouri
1160.26.0027 Boehringer Ingelheim Investigational Site Kalispell Montana
1160.26.0128 Boehringer Ingelheim Investigational Site Alliance Nebraska
1160.26.0110 Boehringer Ingelheim Investigational Site Omaha Nebraska
1160.26.0355 Boehringer Ingelheim Investigational Site Papillion Nebraska
1160.26.0346 Boehringer Ingelheim Investigational Site Henderson Nevada
1160.26.0066 Boehringer Ingelheim Investigational Site Las Vegas Nevada
1160.26.0174 Boehringer Ingelheim Investigational Site Las Vegas Nevada
1160.26.0430 Boehringer Ingelheim Investigational Site Las Vegas Nevada
1160.26.0190 Boehringer Ingelheim Investigational Site Lebanon New Hampshire
1160.26.0142 Boehringer Ingelheim Investigational Site Browns Mills New Jersey
1160.26.0125 Boehringer Ingelheim Investigational Site Cherry Hill New Jersey
1160.26.0432 Boehringer Ingelheim Investigational Site Elmer New Jersey
1160.26.0448 Boehringer Ingelheim Investigational Site Englewood New Jersey
1160.26.0248 Boehringer Ingelheim Investigational Site Flemington New Jersey
1160.26.0244 Boehringer Ingelheim Investigational Site Haddon Heights New Jersey
1160.26.0243 Boehringer Ingelheim Investigational Site New Brunswick New Jersey
1160.26.0478 Boehringer Ingelheim Investigational Site Oakland New Jersey
1160.26.0392 Boehringer Ingelheim Investigational Site Ocean City New Jersey
1160.26.0472 Boehringer Ingelheim Investigational Site Paterson New Jersey
1160.26.0221 Boehringer Ingelheim Investigational Site Voorhees Township New Jersey
1160.26.0254 Boehringer Ingelheim Investigational Site Westwood New Jersey
1160.26.0127 Boehringer Ingelheim Investigational Site Albuquerque New Mexico
1160.26.0423 Boehringer Ingelheim Investigational Site Albuquerque New Mexico
1160.26.0476 Boehringer Ingelheim Investigational Site Albany New York
1160.26.0063 Boehringer Ingelheim Investigational Site Buffalo New York
1160.26.0044 Boehringer Ingelheim Investigational Site Cortlandt Manor New York
1160.26.0373 Boehringer Ingelheim Investigational Site Flushing New York
1160.26.0045 Boehringer Ingelheim Investigational Site Garden City New York
1160.26.0251 Boehringer Ingelheim Investigational Site Kingston New York
1160.26.0229 Boehringer Ingelheim Investigational Site Mineola New York
1160.26.0451 Boehringer Ingelheim Investigational Site Mineola New York
1160.26.0090 Boehringer Ingelheim Investigational Site New Hyde Park New York
1160.26.0183 Boehringer Ingelheim Investigational Site New Rochelle New York
1160.26.0316 Boehringer Ingelheim Investigational Site New York New York
1160.26.0146 Boehringer Ingelheim Investigational Site North Massapequa New York
1160.26.0210 Boehringer Ingelheim Investigational Site Northport New York
1160.26.0075 Boehringer Ingelheim Investigational Site Poughkeepsie New York
1160.26.0197 Boehringer Ingelheim Investigational Site Rochester New York
1160.26.0320 Boehringer Ingelheim Investigational Site Rochester New York
1160.26.0064 Boehringer Ingelheim Investigational Site Scarsdale New York
1160.26.0113 Boehringer Ingelheim Investigational Site The Bronx New York
1160.26.0281 Boehringer Ingelheim Investigational Site The Bronx New York
1160.26.0414 Boehringer Ingelheim Investigational Site Troy New York
1160.26.0356 Boehringer Ingelheim Investigational Site Watertown New York
1160.26.0039 Boehringer Ingelheim Investigational Site Williamsville New York
1160.26.0353 Boehringer Ingelheim Investigational Site Asheville North Carolina
1160.26.0080 Boehringer Ingelheim Investigational Site Charlotte North Carolina
1160.26.0412 Boehringer Ingelheim Investigational Site Charlotte North Carolina
1160.26.0350 Boehringer Ingelheim Investigational Site Gastonia North Carolina
1160.26.0322 Boehringer Ingelheim Investigational Site Greensboro North Carolina
1160.26.0173 Boehringer Ingelheim Investigational Site High Point North Carolina
1160.26.0108 Boehringer Ingelheim Investigational Site Lexington North Carolina
1160.26.0006 Boehringer Ingelheim Investigational Site Pinehurst North Carolina
1160.26.0002 Boehringer Ingelheim Investigational Site Statesville North Carolina
1160.26.0069 Boehringer Ingelheim Investigational Site Statesville North Carolina
1160.26.0372 Boehringer Ingelheim Investigational Site Wilmington North Carolina
1160.26.0094 Boehringer Ingelheim Investigational Site Winston-Salem North Carolina
1160.26.0425 Boehringer Ingelheim Investigational Site Winston-Salem North Carolina
1160.26.0102 Boehringer Ingelheim Investigational Site Grand Forks North Dakota
1160.26.0222 Boehringer Ingelheim Investigational Site Jamestown North Dakota
1160.26.0203 Boehringer Ingelheim Investigational Site Akron Ohio
1160.26.0434 Boehringer Ingelheim Investigational Site Canal Fulton Ohio
1160.26.0083 Boehringer Ingelheim Investigational Site Cincinnati Ohio
1160.26.0402 Boehringer Ingelheim Investigational Site Cincinnati Ohio
1160.26.0426 Boehringer Ingelheim Investigational Site Cincinnati Ohio
1160.26.0479 Boehringer Ingelheim Investigational Site Cincinnati Ohio
1160.26.0263 Boehringer Ingelheim Investigational Site Cleveland Ohio
1160.26.0480 Boehringer Ingelheim Investigational Site Cleveland Ohio
1160.26.0267 Boehringer Ingelheim Investigational Site Columbus Ohio
1160.26.0035 Boehringer Ingelheim Investigational Site Dayton Ohio
1160.26.0150 Boehringer Ingelheim Investigational Site Fairview Park Ohio
1160.26.0201 Boehringer Ingelheim Investigational Site Kettering Ohio
1160.26.0223 Boehringer Ingelheim Investigational Site Lorain Ohio
1160.26.0214 Boehringer Ingelheim Investigational Site Lyndhurst Ohio
1160.26.0275 Boehringer Ingelheim Investigational Site Sandusky Ohio
1160.26.0103 Boehringer Ingelheim Investigational Site Westlake Ohio
1160.26.0155 Boehringer Ingelheim Investigational Site Bartlesville Oklahoma
1160.26.0435 Boehringer Ingelheim Investigational Site Tulsa Oklahoma
1160.26.0139 Boehringer Ingelheim Investigational Site Corvallis Oregon
1160.26.0325 Boehringer Ingelheim Investigational Site Eugene Oregon
1160.26.0078 Boehringer Ingelheim Investigational Site Hillsboro Oregon
1160.26.0245 Boehringer Ingelheim Investigational Site Portland Oregon
1160.26.0133 Boehringer Ingelheim Investigational Site Springfield Oregon
1160.26.0301 Boehringer Ingelheim Investigational Site Allentown Pennsylvania
1160.26.0454 Boehringer Ingelheim Investigational Site Altoona Pennsylvania
1160.26.0295 Boehringer Ingelheim Investigational Site Camp Hill Pennsylvania
1160.26.0294 Boehringer Ingelheim Investigational Site Hershey Pennsylvania
1160.26.0369 Boehringer Ingelheim Investigational Site Jenkintown Pennsylvania
1160.26.0303 Boehringer Ingelheim Investigational Site Jersey Shore Pennsylvania
1160.26.0431 Boehringer Ingelheim Investigational Site Lancaster Pennsylvania
1160.26.0168 Boehringer Ingelheim Investigational Site Langhorne Pennsylvania
1160.26.0293 Boehringer Ingelheim Investigational Site Meadowbrook Pennsylvania
1160.26.0025 Boehringer Ingelheim Investigational Site Newton Pennsylvania
1160.26.0394 Boehringer Ingelheim Investigational Site Norristown Pennsylvania
1160.26.0158 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania
1160.26.0181 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania
1160.26.0416 Boehringer Ingelheim Investigational Site Philadelphia Pennsylvania
1160.26.0344 Boehringer Ingelheim Investigational Site Pittsburgh Pennsylvania
1160.26.0466 Boehringer Ingelheim Investigational Site Pittsburgh Pennsylvania
1160.26.0208 Boehringer Ingelheim Investigational Site Sellersville Pennsylvania
1160.26.0465 Boehringer Ingelheim Investigational Site Uniontown Pennsylvania
1160.26.0400 Boehringer Ingelheim Investigational Site Upland Pennsylvania
1160.26.0032 Boehringer Ingelheim Investigational Site Wynnewood Pennsylvania
1160.26.0067 Boehringer Ingelheim Investigational Site Wyomissing Pennsylvania
1160.26.0212 Boehringer Ingelheim Investigational Site Pawtucket Rhode Island
1160.26.0007 Boehringer Ingelheim Investigational Site Beaufort South Carolina
1160.26.0383 Boehringer Ingelheim Investigational Site Charleston South Carolina
1160.26.0313 Boehringer Ingelheim Investigational Site Greenville South Carolina
1160.26.0450 Boehringer Ingelheim Investigational Site Mt. Pleasant South Carolina
1160.26.0166 Boehringer Ingelheim Investigational Site Spartanburg South Carolina
1160.26.0008 Boehringer Ingelheim Investigational Site Summerville South Carolina
1160.26.0468 Boehringer Ingelheim Investigational Site West Columbia South Carolina
1160.26.0348 Boehringer Ingelheim Investigational Site Rapid City South Dakota
1160.26.0084 Boehringer Ingelheim Investigational Site Chattanooga Tennessee
1160.26.0062 Boehringer Ingelheim Investigational Site Germantown Tennessee
1160.26.0370 Boehringer Ingelheim Investigational Site Johnson City Tennessee
1160.26.0323 Boehringer Ingelheim Investigational Site Nashville Tennessee
1160.26.0395 Boehringer Ingelheim Investigational Site Nashville Tennessee
1160.26.0474 Boehringer Ingelheim Investigational Site Oak Ridge Tennessee
1160.26.0129 Boehringer Ingelheim Investigational Site Austin Texas
1160.26.0410 Boehringer Ingelheim Investigational Site Austin Texas
1160.26.0156 Boehringer Ingelheim Investigational Site Dallas Texas
1160.26.0315 Boehringer Ingelheim Investigational Site Fort Worth Texas
1160.26.0444 Boehringer Ingelheim Investigational Site Fort Worth Texas
1160.26.0447 Boehringer Ingelheim Investigational Site Houston Texas
1160.26.0483 Boehringer Ingelheim Investigational Site Killeen Texas
1160.26.0335 Boehringer Ingelheim Investigational Site Lubbock Texas
1160.26.0230 Boehringer Ingelheim Investigational Site McKinney Texas
1160.26.0467 Boehringer Ingelheim Investigational Site Plano Texas
1160.26.0013 Boehringer Ingelheim Investigational Site San Antonio Texas
1160.26.0269 Boehringer Ingelheim Investigational Site San Antonio Texas
1160.26.0307 Boehringer Ingelheim Investigational Site San Antonio Texas
1160.26.0285 Boehringer Ingelheim Investigational Site San Marcos Texas
1160.26.0215 Boehringer Ingelheim Investigational Site Tyler Texas
1160.26.0367 Boehringer Ingelheim Investigational Site Tyler Texas
1160.26.0195 Boehringer Ingelheim Investigational Site Arlington Virginia
1160.26.0453 Boehringer Ingelheim Investigational Site Charlottesville Virginia
1160.26.0053 Boehringer Ingelheim Investigational Site Chesapeake Virginia
1160.26.0098 Boehringer Ingelheim Investigational Site Danville Virginia
1160.26.0386 Boehringer Ingelheim Investigational Site Falls Church Virginia
1160.26.0428 Boehringer Ingelheim Investigational Site Fredericksburg Virginia
1160.26.0311 Boehringer Ingelheim Investigational Site Harrisonburg Virginia
1160.26.0292 Boehringer Ingelheim Investigational Site Newport News Virginia
1160.26.0224 Boehringer Ingelheim Investigational Site Norfolk Virginia
1160.26.0220 Boehringer Ingelheim Investigational Site Salem Virginia
1160.26.0317 Boehringer Ingelheim Investigational Site Winchester Virginia
1160.26.0287 Boehringer Ingelheim Investigational Site Bellevue Washington
1160.26.0050 Boehringer Ingelheim Investigational Site Bellingham Washington
1160.26.0040 Boehringer Ingelheim Investigational Site Burien Washington
1160.26.0298 Boehringer Ingelheim Investigational Site Olympia Washington
1160.26.0250 Boehringer Ingelheim Investigational Site Spokane Washington
1160.26.0256 Boehringer Ingelheim Investigational Site Tacoma Washington
1160.26.0024 Boehringer Ingelheim Investigational Site Wenatchee Washington
1160.26.0193 Boehringer Ingelheim Investigational Site Charleston West Virginia
1160.26.0169 Boehringer Ingelheim Investigational Site Clarksburg West Virginia
1160.26.0365 Boehringer Ingelheim Investigational Site Huntington West Virginia
1160.26.0072 Boehringer Ingelheim Investigational Site Elkhorn Wisconsin
1160.26.0234 Boehringer Ingelheim Investigational Site Green Bay Wisconsin
1160.26.0099 Boehringer Ingelheim Investigational Site Madison Wisconsin
1160.26.0242 Boehringer Ingelheim Investigational Site Madison Wisconsin
1160.26.0359 Boehringer Ingelheim Investigational Site Marshfield Wisconsin
1160.26.0461 Boehringer Ingelheim Investigational Site Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 610 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00262600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00262600 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →